Delivery Order SPE2DB20D3104-SPE2DB23FV9B1

Award Date 9/13/23
Potential Completion Date 9/14/23
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NEXLETOL 180 MG TABLET. The $3,158.77 firm fixed-price contract has a completion date of July 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.46, is a delivery order without any set-aside designation, indicating open competition. It covers the supply of NEXLETOL 180 MG TABLET to support military healthcare programs. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,079.04 firm fixed price delivery order is for 4566327881 ! NEXLETOL 180 MG TABLET UU 30S, a pharmaceutical product, with a completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,213.53 firm fixed-price delivery order is for the supply of NEXLETOL 180 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,262.86 issued by the Defense Logistics Agency (DLA). The contract is for the supply of NEXLETOL 180 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and is a Firm Fixed Price contract type. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.15 firm fixed-price delivery order is for the supply of NEXLETOL 180 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,846.10 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 29, 2023. The award is for the supply of NEXLETOL 180 MG TABLET, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,892.62, is for the delivery of a pharmaceutical product, specifically NEXLETOL 180 MG TABLET, and is classified as a Firm Fixed Price Delivery Order. The award is not designated as a set-aside contract. This contract is associated with a larger Indefinite Delivery Contract...
This federal contract award, valued at $14,093.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the purchase of NEXLIZET 180-10 MG TABLET in quantities of 30s. This award does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of medical supplies, specifically Nexletol 180 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under their existing Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV9B1
    Delivery Order

This federal contract award, valued at $1,834.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nexletol 180 mg tablets and does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:31 AM